Oswin Ridderbusch is a German and European patent attorney and a partner at the IP law firm Vossius based in Munich, Germany. He graduated in biochemistry from the University of Tübingen, focusing on medicinal chemistry and protein biochemistry, and conducted research at the Max Planck Institute for Developmental Biology. His practice includes the drafting and prosecution of patent applications, mainly in the fields of pharmaceuticals and biotechnology, the filing of supplementary protection certificates, as well as contentious post-grant proceedings including opposition, revocation and infringement actions. Oswin is an editor and author of the handbooks “European SPCs Unravelled: A Practitioner’s Guide to Supplementary Protection Certificates in Europe” and “Antibody Patenting: A Practitioner’s Guide to Drafting, Prosecution and Enforcement”. He engages in the AIPPI standing committee on the Unitary Patent and the Unified Patent Court.